Location permission needed for a better experience.
How can we help you?
CV
MEMBERSHIPS
PUBLICATIONS
EDUCATION
  • 2017 Memorial Şişli Hastanesi Tüp Bebek Merkezi Üremeye Yardımcı Tedavi Uygulamaları Eğitimi
  • 2014 Ankara Üniversitesi Tıp Fakültesi Kadın Hastalıkları ve Doğum
  • 2006 Hacettepe Üniversitesi Tıp Fakültesi
EXPERIENCE
  • 2022 Acıbadem Sağlık Grubu
  • 2016 - 2022 Memorial Ataşehir Hastanesi Kadin Hastalıkları ve Doğum
  • 2014 - 2016 Taşköprü Devlet Hastanesi (devlet hizmet yükümlülüğü)/Uzman Doktor
MEMBERSHIPS
  • ESHRE Avrupa İnsan Üremesi ve Embriyoloji Derneği
  • Türk Jinekoloji ve Obstetri Derneği (TJOD)
  • Üreme Tıbbı Cerrahi Derneği(UTCD)
  • Minimal İnvaziv Jinekoloji Derneği(MİJİD)
  • ASRM Amerikan Üreme Tıbbı Derneği
PUBLICATIONS
  • Comparison of pregnancy and live birth rates between fresh day 5 morula transfer and fresh day 6 blastocyst transfer following extended culture for slow growing embryos Arch Gynecol Obstet. 2022 Oct;306(4):1273-1280. doi: 10.1007/s00404-022-06661-7. Epub 2022 Jul 13. TÜLEK FIRAT, Kahraman Alper.
  • The effects of intra-ovarian autologous platelet rich plasma injection on IVF outcomes of poor responder women and women with premature ovarian insufficiency. Journal of the Turkish-German Gynecological Association, 23(1), 14-21., Doi:10.4274/jtgga.galenos.2021. (2022) TÜLEK FIRAT, Kahraman Alper
  • Dual trigger with gonadotropin releasing hormone agonist and human chorionic gonadotropin improves live birth rates in POSEIDON group 3 and 4 expected poor responders. Gynecol Endocrinol. 2022 Sep;38(9):731-735. doi: 10.1080/09513590.2022.2101635. Epub 2022 Jul 20. TÜLEK FIRAT, Kahraman Alper, Demirel Cem.
  • Low first trimester maternal serum PAPP-A concentrations in women with non-cavity-distorting intramural uterine fibroids Journal of Obstetrics and Gynaecology Research, Doi: 10.1111/jog.15188 (2022) Kahraman Alper, TÜLEK FIRAT
  • Effects of growth hormone co-treatment on in vitro fertilization outcomes in women with expected normal ovarian response Turkish Journal of Obstetrics and Gynecology, 18(4), 285-290., Doi: 10.4274/tjod.galenos.2021.03439 (2021) TÜLEK FIRAT, Kahraman Alper
  • Fertility outcomes after preconceptional laparoscopic abdominal cerclage for second-trimester pregnancy losses European Journal of Obstetrics & Gynecology and Reproductive Biology, 257, 59-63., Doi: 10.1016/j.ejogrb.2020.12.012 (2021) Demirel Cem, GÖKSEVER ÇELİK HALE, TÜLEK FIRAT, Kucukdemir Bengisu, GÖKALP DENİZ, ERGİN TOLGA, LEMBET AHMET ARDA
  • Analysis of the association between minor cervical cytological abnormalities and consequent pathology result in accordance with HPV types Southern Clinics of Istanbul Eurasia, 32(4), 371-375., Doi: 10.14744/scie.2021.52207 (2021) Kahraman Alper, TÜLEK FIRAT
  • The impact of a poor quality embryo on the implantation chance of a good quality one when transferred together: A study on double blastocyst transfers Journal of Gynecology Obstetrics and Human Reproduction, 50(6), 1-6., Doi: 10.1016/j.jogoh.2020.101967 (2021) Demirel Cem, GÖKSEVER ÇELİK HALE, TÜLEK FIRAT, Tuysuz Gulsum, Donmez Ersan, ERGİN TOLGA, BUYRU HASAN FARUK, BAŞTU ERCAN
  • Failure to Detect Viral RNA in Follicular Fluid Aspirates from a SARS-CoV-2-Positive Woman Reproductive Sciences, 28, 2144-2146., Doi: 10.1007/s43032-021-00502-9 (2021) Demirel Cem, TÜLEK FIRAT, GÖKSEVER ÇELİK HALE, Donmez Ersan, Tuysuz Gulsum, Gökcan Bilgi
  • Dual Trigger with Gonadotropin-releasing Hormone Agonist and Human Chorionic Gonadotropin Improves Live Birth Rate for Women with Expected Normal Ovarian Response in Gonadotropin Releasing Hormone Antagonist Cycles: Retrospective Study. Journal of Clinical Obstetrics & Gynecology, 31(3), 89-96., Doi: 10.5336/jcog.2021-86043 (2021) TÜLEK FIRAT, Kahraman Alper
  • Primary mucinous carcinoma of the vulva with signet ring cells deriving from the cloaca Eur J Gynaecol Oncol. 2016 Aug;37(4):554-557. PMID: 29894084. (2016) TÜLEK FIRAT,, Kahraman Alper, Taskin Salih, Yuksel Seher, Sertcelik Ayşe, Ortac Firat
  • The effects of isolated single umbilical artery on first and second trimester aneuploidy screening test parameters J Matern Fetal Neonatal Med. 2015 Apr;28(6):690-4. doi: 10.3109/14767058.2014.928856. Epub 2014 Jun 26. PMID: 24866346. TÜLEK FIRAT, Kahraman Alper, Taşkın Salih, Özkavukçu Esra, Söylemez Feride
  • Changes in first trimester screening test parameters in pregnancies complicated by placenta previa and association with hyperemesis gravidarum J Turk Ger Gynecol Assoc. 2014 Dec 1;15(4):212-6. doi: 10.5152/jtgga.2014.14045. PMID: 25584028; PMCID: PMC4285208. TÜLEK FIRAT, Kahraman Alper, Taşkın Salih, Özkavukçu Esra, Söylemez Feride

INFORMATION FORM WITH REGARD TO OBTAINING AND PROCESSING OF PERSONAL DATA

Acıbadem Sağlık Hizmetleri ve Ticaret A.Ş. (“Acıbadem”) and Acıbadem’s controlling shareholders, parent companies and affiliates (hereinafter to be collectively referred to as “Acıbadem Group”) may, acting as “Data Supervisor” under the Law on Protection of Personal Data no. 6698 (the “Law”) and other pertinent laws and regulations, process your personal data within the following frame and in strict compliance with the Basic Healthcare Services Law no. 3359, the Governmental Decree-Law on Organization and Duties of the Ministry of Health and its Affiliated Companies no. 663, the Private Hospitals Regulation, and other regulations of the Ministry of Health, and other applicable laws and provisions.

1. Obtaining and Processing of Personal Data, and Purposes of Processing:

Your personal data is collected and obtained verbally, in writing, or in visual or electronic media, through call center, internet site, verbally, in writing or similar other channels for conduct of such services as protection of public health, preventive medicine, medical diagnosis, treatment and maintenance services offered by Acıbadem Group, or for planning and management of healthcare services and financing, and in accordance with the fields of business of Acıbadem Group Companies. Your general personal data and special personal data, especially your healthcare data, may be processed by the Group to a limited extent for all and any purposes, including, but not limited to, the following purposes:

All kinds of your personal data obtained by Acıbadem Group (including, but not limited to, your special personal data) may be processed for the following purposes:

Your personal data obtained and processed pursuant to the applicable laws and regulations may be transferred to physical archives and/or information systems of Acıbadem or Acıbadem Group and may be kept and stored both in digital and in physical platforms.

2. Transfer of Personal Data

Your personal data may be shared by Acıbadem and Acıbadem Group with companies included in Acıbadem Group or with private insurance companies, Ministry of Health and its sub-units, Social Security Agency, Security General Directorate and other security forces, General Directorate of Population and Census, Turkish Pharmacists’ Association, courts and all kinds of other juridical authorities, central etc. third parties, your authorized representatives and agents, and third parties offering consulting and advice services to us, including, but not limited to, lawyers, tax and financial consultants and auditors, and our business partners and other third parties acting in cooperation with us for further development or performance of healthcare services for the purposes cited above, also including regulatory and supervisory bodies and authorities, and official authorities, for the purposes of processing listed above, in accordance with the Law and other applicable laws and regulations.

3. Methods and Legal Causes of Obtaining of Personal Data

Your personal data are collected and processed in all kinds of verbal, written, visual or electronic media, for the purposes listed hereinabove, and for performance of all kinds of works included in the fields of business of Acıbadem within the legal framework, and accordingly, for full and proper performance of all kinds of contractual and legal duties and obligations of Acıbadem. Legal causes of collection and acquisition of your personal data are the pertinent provisions of:

Furthermore, as stipulated in 3rd paragraph of article 6 of the Law, personal data relating to health may also be processed by persons under secrecy obligations or by authorized official entities and organizations, without being liable to receive prior explicit consent of the relevant purpose, only for protection of public health, preventive medicine, medical diagnosis, treatment and maintenance services, and for planning and management of healthcare services and financing.

4. Your Rights Regarding Protection of Personal Data

Pursuant to the Law and other relevant applicable laws and regulations, you are entitled:

If at any time you use any one or more of your aforesaid rights, the relevant information will be transmitted to you clearly and in an understandable manner, in writing or in electronic media, by using the communication data and information provided by you.

5. Data Security

Acıbadem protects your personal data in full and strict compliance with all technical and administrative security controls required to be taken in accordance with information security standards and procedures. Said security actions and measures are taken and provided at a level appropriate for the probable risks by also taking into consideration the technological possibilities.

6. Complaints and Communications

Your personal data are protected within the frame of the available technical and administrative possibilities, and the required security actions and measures are taken and provided at a level appropriate for the probable risks by also taking into consideration the technological possibilities.

By filling in the “Application Form Pursuant to the Law on Protection of Personal Data” given at the , “https://www.acibadem.com.tr/acibademonline/hastaverilerinkorunmasi.html” web address, you may transmit and submit your legal requests:

You are hereby kindly requested to transmit your legal requests under the Law by filling in the “Application Form Pursuant to the Law on Protection of Personal Data” given at the https://www.acibadem.com.tr/acibademonline/hastaverilerinkorunmasi.html web address and sending it to us by the communication means set forth in the form.

TOP